People Finder


Dave Knaack

Director, Technology Transfer

Office for Technology Transfer

Office Phone: +1 508 289 3556

WHOI Mailing Address:

Woods Hole Oceanographic Institution

266 Woods Hole Rd.

MS# 53

Woods Hole, MA 02543-1050

Research Statement

Issued US Patents



Injectable and moldable bone substitute materials



Synthesis of a bone-polymer composite material



Tissue-derived mesh for orthopedic regeneration



Coupling agents for orthopedic biomaterials



Hemostatic bone graft



Polyurethanes for osteoimplants



Non-glycerol stabilized bone graft



Polyurethanes for osteoimplants



Polyurethanes for osteoimplants



Bone graft comprising a demineralized bone matrix and a stabilizing agent



Coupling agents for orthopedic biomaterials



Bone graft



Malleable implant containing solid element that resorbs or fractures to provide access channels



Glucose responsive insulin secreting .beta.-cell lines and method for producing same



Glucose responsive insulin secreting .beta.-cell lines and method for producing same



Glucose responsive insulin secreting .beta.-cell lines and method for producing same

Personal Statement

David Knaack, Ph.D. joined WHOI in 2013 as the Director for Technology Transfer with responsibilities for Commercializing New Technologies arising from WHOI’s relationship with the sea. In addition to marketing and licensing of new technologies, his role includes identifying, patenting and facilitating applied research for product advancement

Dr. Knaack joined WHOI after 24 years in the Medical Device/Biotech industry where he held leadership positions of increasing responsibilities in Product Development and Research, most recently as Vice President of Product Development & Manufacturing at ORTHOCON/ABYRX, Inc.  His leadership roles in four biomedical startups have given him a breadth of experience in product development, quality systems, regulatory, project management and the strategic development and commercialization of intellectual property.  His areas of technical expertise include: implantable medical devices, biomaterials and composites, biologically active molecules, polymer-tissue composites, and cell line development. He has expertise in a number of therapeutic areas including Diabetes, neurodegeneration, orthopedics, analgesia and hemostasis. Dr. Knaack is a registered patent agent with publications in the fields of biocomposites and biomaterials as well as in tissue engineering and cell and molecular biology. He is a named inventor on sixteen issued U.S. patents and agent of record on two others. He holds a B.Sci. in Chemistry from St. Lawrence University and a Ph.D. in Neurochemistry from Cornell University. He completed post-doctoral work in Molecular Biology at Harvard Medical School as a Howard Hughes Fellow.